NCT00927537View on ClinicalTrials.gov

Therapy of Essential Hypertension With Kinzal®/ Kinzalplus®

CompletedOBSERVATIONAL
Enrollment

2,052

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Hypertension
Interventions
DRUG

Telmisartan (Kinzal/Pritor, BAY68-9291)

Patients under daily life treatment receiving Kinzal according to local drug information.

DRUG

Telmisartan (Kinzal/Pritor, BAY68-9291) + Hydrochlorothiazide

Patients under daily life treatment receiving Kinzalplus according to local drug information.

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY